Supporting Innovation through Regulation and Science Larry O Dwyer, Scientific Affairs Manager PEARRL Regulatory Science Symposium 21 st June 2017, School of Pharmacy, UCC
Overview of Presentation Drivers for innovation Some HPRA activities to support innovation Education and Outreach Horizon-scanning Classification Innovation Office 15/06/2017 2
Drivers for Innovation
Population Demographics are Changing Source: Aging with Tech Support McKinsey and Company Sept 2016 15/06/2017 4
Treatment Needs are Changing Cancer Ageing Population Long-Term Chronic Diseases Cardiovascular Disease Respiratory Disease Cancer Diabetes 15/06/2017 5
Treatment Needs are Changing Cancer Ageing Population Long-Term Chronic Diseases Cardiovascular Disease Respiratory Disease Cancer Diabetes 15/06/2017 6
Patients Knowledge and Expectations are Increasing Source: Future of Ireland III, Innovation Matters www.futureofireland.ie 15/06/2017 7
15/06/2017 8 The Life-Sciences Sector is Changing More collaboration between industry and academia and partnerships between companies Looking for newer R&D models New technologies providing opportunities
New Medicines in the EU 2010-2012 Proportion of New Medicines (%) 28% 59% 21% 28% 27% 13% 17% Originator MAH 0 7% 0 Large Company Intermediate-sized Company SME Academia/public bodies / PPPs Private Collaborations Significant % of new medicines originated from SMEs and Academia Source: H. Lincker et al Nature Reviews Drug Discovery Vol 13 pp 92-93 (2014) 15/06/2017 9
Sources of Innovation 15/06/2017 10
Percentage of Global R&D Spending in 2016, by industry Source: statistica.com 15/06/2017 11
Clinical Trials 15/06/2017 12
Clinical Trials Use of Selection Biomarkers Source: Clinical Development Success Rates 2006-2015, BIO, Biomedtracker, Amplion 15/06/2017 13
Examples of Novel Technologies / Product Types 3D Printing Robotics Drug-Device Combinations 15/06/2017 14
HPRA Activities to Support Innovation
Supporting Innovation A key Strategic objective 15/06/2017 16
15/06/2017 17 Examples of Some Recent Initiatives to Support Innovation National Scientific Advice Outreach Programme Involvement in Regulatory Science Ireland Horizon Scanning Involvement in PEARRL Supporting Innovation Innovation Office
Education and Outreach HPRA contributes to undergraduate courses and taught Masters in relevant disciplines Focus of outreach includes third level institutes, research and technology centres, SMEs Aim is to understand needs of researchers, agree engagement methods, increase awareness of the role and activities of HPRA 15/06/2017 18
15/06/2017 19 Horizon-Scanning Using internal and external sources of intelligence Aims are to inform need for: future regulatory changes, enhanced outreach, development of additional expertise, new ways of working
15/06/2017 20 Classification Important to identify the regulatory framework that will apply to an innovation at an early stage of development HPRA has a classification procedure for borderline products: medicines / medical devices / cosmetics / non-medicinal (e.g. foods) Details available on HPRA website Borderlines may be subject to change with the impact of legislation, e.g., new medical devices legislation, EU review of botanicals
15/06/2017 21 HPRA Innovation Office Launched in Nov 2016 An initial point of contact for innovators to submit queries in relation to innovative products and technologies within the HPRA s remit Queries can be submitted at any stage of development including initial research HPRA is also part of the EU Innovation Network
Submissions to the Innovation Office Query Submission via a dedicated online form or a dedicated email address Request for general guidance on regulatory / scientific issues HPRA Review Response Queries will be reviewed by relevant HPRA experts Written response will generally be sent within 20 working days Response may recommend more detailed scientific advice May propose meeting or further interaction as development proceeds 15/06/2017 22
15/06/2017 23 Topics Addressed in Innovation Office Queries 5% 5% 5% 9% Medical Devices Medicines 43% Drug / Device Combinations 33% Diagnostics Cosmetics Other
15/06/2017 24 Origin of Innovation Office Queries 4% 9% 9% 14% SME 32% 32% Academia Life Sciences Industry Individuals Consortium Others / Unknown
15/06/2017 25
15/06/2017 26 Benefits from Supporting Innovation Support the dynamic innovative environment within Ireland Strengthen links between HPRA and Innovators Clarify regulatory requirements at an early stage and help to avoid issues at later stages of development Inform the future development of the HPRA Ensure that the HPRA is well positioned to take a lead role in relation to the regulation of innovative products and technologies at a European and international level Patients will benefit via the facilitation of more timely access to innovative health products
Thank you Contact the innovation office via our website: www.hpra.ie Email: innovationoffice@hpra.ie 15/06/2017 27